Want to see JSPR full AI Analyst Report?
Jasper Therapeutics (JSPR) Q4 2024 Earnings Report
JSPR Q4 2024 EPS Results
- Actual EPS
- -$1.62
- Consensus EPS
- -$1.25
- Beat/Miss
- Missed by -$0.37
- One Year Ago EPS
- -$1.50
JSPR Q4 2024 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q4 2024
- Date
- 02/27/2025
- Time
- Before Open
- Conference Call
- Thursday, February 27, 2025
JSPR Upcoming Earnings
Jasper Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q4 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
JSPR Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | -0.06- | -1.13 | ― | ― |
| Aug 14, 2026 | 2026 (Q2) | -0.27-0.10 | -1.74 | 94.25% (+1.64) | |
| May 14, 2026 | 2026 (Q1) | -0.49-0.04 | -1.41 | 97.16% (+1.37) | |
| Mar 30, 2026 | 2025 (Q4) | -0.80-0.32 | -1.62 | 80.25% (+1.30) | |
| Nov 10, 2025 | 2025 (Q3) | -1.22-1.13 | -1.24 | 8.87% (+0.11) | |
| Aug 13, 2025 | 2025 (Q2) | -1.33-1.74 | -0.97 | -79.38% (-0.77) | |
| May 12, 2025 | 2025 (Q1) | -1.35-1.41 | -1.03 | -36.89% (-0.38) | |
| Feb 27, 2025 | 2024 (Q4) | -1.25-1.62 | -1.5 | -8.00% (-0.12) | |
| Nov 07, 2024 | 2024 (Q3) | -1.07-1.24 | -1.6 | 22.50% (+0.36) | |
| Aug 13, 2024 | 2024 (Q2) | -1.09-0.97 | -1.5 | 35.33% (+0.53) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
